A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types

Clinical and Translational Medicine

Table 2 Patients’ characteristics

Patient number	Age	Sex	CEA (ng/ml)	Location	Tumor size on CT (mm)	Histological type		TNM classification	EGFR mutation
2	55	M	3.9	Rt.S1	11	pseudo-Normal^a	AIS	T1aN0M0	Unkown
4	59	W	8.1	Lt.S1 + 2	15	pseudo-Normal^a	LPIA	T1bN0M0	Unkown
9	55	W	5.3	Rt.S4	37	pseudo-Normal^a	LPIA	T1bN0M0	Unkown
1	63	W	1.9	Rt.S2	15	Adenocarcinoma	AIS	T1aN0M0	Unkown
2	55	M	3.9	Rt.S1	11	Adenocarcinoma	AIS	T1aN0M0	Unkown
3	56	W	2	Lt.S8	10	Adenocarcinoma	AIS	T1aN0M0	Unkown
4	59	W	8.1	Lt.S3	28	Adenocarcinoma	MIA	T1bN0M0	Unkown
5	73	W	5.4	Rt.S5	25	Adenocarcinoma	MIA	T1bN0M0	Unkown
6	74	W	1.5	Lt.S3	25	Adenocarcinoma	MIA	T1bN0M0	L858R
7	78	W	1.5	Rt.S3	37	Adenocarcinoma	LPIA	T2aN0M0	L858R
8	72	W	0.6	Rt.S1	51	Adenocarcinoma	LPIA	T2aN0M0	Unkown
9	55	W	5.3	Rt.S4	37	Adenocarcinoma	LPIA	T1bN0M0	Unkown